An extracellular cytolytic toxin produced by the halophilic bacterium Vibrio vulnificus was isolated free of detectable contamination with medium constituents and other bacterial products by sequential ammonium sulfate precipitation, gel filtration with Sephadex G-75, hydrophobic interaction chromatography with phenyl-Sepharose CL-4B, and isoelectric focusing in an ethylene glycol density gradient. The cytolysin is a heat-labile, hydrophobic protein that is inhibited by large amounts of cholesterol, is partially inactivated by proteases and trypan blue, has a molecular weight (estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and by amino acid analysis) of ca. 56,000, and has an isoelectric point of ca. 7.1. The first 10 amino-terminal amino acid residues of the cytolysin are Gln-Glu-Tyr-Val-Pro-Ile-Val-Glu-Lys-Pro. Lysis of mouse erythrocytes by the purified cytolysin is a multi-hit, at least two-step process consisting of a temperature-independent, toxin-binding step, followed by a temperature-dependent, membrane-perturbation step(s). In addition to possessing cytolytic activity against erythrocytes from 17 animal species and against Chinese hamster ovary cells in tissue culture, the purified cytolysin preparation was lethal for mice (ca. 3 ,ug/kg, intravenous 50% lethal dose) and had vascular permeability factor activity in guinea pig skin.
The final purified cytolysin preparation (stage 5), freed of ethylene glycol by gel filtration with Sephadex G-25 (Pharmacia Fine Chemicals, Piscataway, N.J.), was assayed for cytotoxicity against Chinese hamster ovary cells, vascular permeability factor activity in guinea pig skin, and lethal activity for mice as previously described for crude preparations of the cytolysin (22) .
The final purified cytolysin preparation (100 ,ul) was examined for protease activity against azocasein as previously described (24) , except the assay mixtures were incubated for 20 min instead of 10 min at 37°C.
The final purified cytolysin preparation (100 ,ul) was examined for the presence of lipopolysaccharide endotoxin (Escherichia coli endotoxin standard) by the Limulus amebocyte lysate method with commercially available lysate (Pyrostat; Worthington Diagnostics, Inc., Freehold, N.J.) as recommended by the manufacturer.
Protein was estimated by the method of Bradford (9) , with bovine gamma globulin as the standard. The standard and the assay reagent were obtained from Bio-Rad Laboratories, Inc., Richmond, Calif.
Bacterium and preparation of seed cultures. V. vulnificus E4125 was kindly supplied by R. E. Weaver and D. G. Hollis of the Centers for Disease Control, Atlanta, Ga. Seed cultures were prepared as previously described (22) , except the sheep blood was omitted from the Columbia agar plates.
Purification of cytolysin. Unless otherwise noted, all steps were done at approximately 4°C. Stage 1. Culture supernatant fluids. Twelve 2-liter Erlenmeyer flasks containing 200 ml of heart infusion diffusate broth (23) were inoculated with portions (0.3 to 0.4 ml containing 10 optical density units at 650 nm and ca. 1010 CFU) of a seed culture suspension, and the culture super-V. VULNIFICUS CYTOLYSIN 63 natant fluids were obtained by centrifugation (16,000 x g, 20 min) after incubation of the cultures for 4 to 6 h at 37°C on a Gyrotory shaker (model G-25; New Brunswick Scientific Co., Edison, N.J.) operating at 220 cycles per min.
Stage 2. Ammonium sulfate precipitation. Ammonium sulfate (enzyme grade; Schwarz/Mann, Cambridge, Mass.) was dissolved in the pooled culture supernatant fluids to a final concentration of ca. 50% saturation (350 g/liter). After 16 to 18 h, the precipitate was recovered by centrifugation (16,000 x g, 20 min) and dissolved in 60 ml of deionized water. The solution was centrifuged (20,000 x g, 20 min) to remove a small amount of insoluble residue, and ammonium sulfate was dissolved in the supernatant fluids to a final concentration of ca. 40% saturation (280 g/liter). After 16 to 18 h, the precipitate was recovered by centrifugation (20,000 x g, 20 min) and was dissolved in 10 ml of 10 mM glycine-NaOH buffer (pH 9.8) supplemented with 20 mM NaCl. A small amount of insoluble residue was removed from the solution by centrifugation.
Stage 3. Sephadex G-75 gel filtration. The stage 2 preparation was applied to a column (2.6 by 96 cm) of Sephadex G-75 (Pharmacia) equilibrated with the same glycine buffer used in stage 2 and was eluted at a flow rate of 20 ml/h (ca.
3.8 ml/cm2 per h). Fractions (5 ml) were assayed for absorbance at 280 nm and for cytolytic activity and were analyzed by fused rocket immunoelectrophoresis. The cytolysin peak fractions (usually eight or nine fractions) were pooled.
Stage 4. Hydrophobic interaction chromatography. The stage 3 pool was applied to a column (1.6 by 30 cm) of phenyl-Sepharose CL-4B (Pharmacia) equilibrated with the same glycine buffer used in stage 2 and the column was washed (40 ml/h; 4-ml fractions collected) with 3 to 4 bed volumes (180 to 240 ml) of 25% ethylene glycol (EG) in 10 mM glycine-NaOH buffer (pH 9.8). The cytolysin was eluted by washing the column (8 to 12 ml/h; 2-to 3-ml fractions collected) with 50% EG in 2 mM glycine-NaOH buffer (pH 9.8). The fractions were assayed for absorbance at 280 nm and for cytolytic activity, and were analyzed by fused rocket immunoelectrophoresis. The cytolysin peak fractions (usually 10 fractions) were pooled.
Stage 5. Isoelectric focusing. The stage 4 pool was fractionated by high-speed electrofocusing (45) in a pH 6 to 8 EG density gradient formed at 15 W for 18 h with an LKB 8100-1 column (LKB Instruments, Inc., Gaithersburg, Md.). The pH of each fraction (4 ml) was determined at 4°C, and the fractions were assayed for cytolytic activity and analyzed by fused rocket immunoelectrophoresis. The cytolysin peak fractions (usually five fractions) were pooled and stored at -700C.
Preparation of antiserum. A crude cytolysin preparation was obtained from the culture supernatant fluids by precipitation with ammonium sulfate (350 g/liter) as described in the stage 2 protocol, except the preparation was lyophilized after being dissolved in deionized water and phosphatidylserine, phosphatidylinositol, and phosphatidylethanolamine [Serdary Research Laboratories, London, Ontario, Canada]). The organic solvents in which the lipids were dissolved were evaporated with a stream of nitrogen, and the lipids were suspended in 0.9 ml of PBS by blending with a Vortex mixer for 1 min. The cytolysin-reagent mixtures (1 ml, final volume) were incubated at 25°C for 15 min before assay for residual activity.
The effect of dithiothreitol (electrophoresis grade; BioRad Laboratories), various divalent cations (Ca2 , Mg2+, Zn2+), and chelating agents [ethylene glycol-bis(,Baminoethyl ether)-N,N-tetraacetic acid (EGTA) and disodium EDTA] on cytolysin activity was examined by assaying the cytolysin in the presence of the reagents (i.e., (40) recently observed that cytolysin production by V. vulnificus was optimal in heart infusion broth containing 0.5 to 1.5% NaCl, and that glucose reduced cytolysin yield.
Purification of cytolysin. The behavior of the V. vulnificus cytolysin during sequential gel filtration, hydrophobic interaction chromatography, and isoelectric focusing is shown in Fig. 1, 2 , and 3, respectively, and the quantitative results of the purification scheme are summarized in Table 1 . The behavior of the cytolysin during hydrophobic interaction chromatography (i.e., binding at pH 9.8 in the presence of 25% ethylene glycol) indicates that the cytolysin is strongly hydrophobic. The recovery and specific activity of cytolysin in six different stage 5 preparations ranged from 20 to 25% and from 70,000 to 90,000 HU/mg protein, respectively. The stage 5 cytolysin preparation was homogeneous by crossed immunoelectrophoresis (Fig. 4) and analytical thin-layer isoelectric focusing in polyacrylamide gel (Fig. SA) high-molecular-weight component seen in nonreduced preparations, but revealed a major band (88% of the Coomassie blue-staining material) with a molecular weight of ca. 56,000 and two minor bands with molecular weights of ca. 48,000 and 16,500 and containing ca. 8 and 4% of the Coomassie blue-staining material, respectively. The similarity of the combined molecular weight of the two minor components (64,500) and the molecular weight of the major component (56,000), and the unlikely possibility that contaminants would be associated with the cytolysin by disulfide bonds during purification of the cytolysin, suggest that the two minor components are fragments of the cytolysin. Increasing the exposure of the cytolysin to the disruption solution from 2 min to 1 h, increasing the concentrations of SDS and P-mercaptoethanol in the disruption solution from 4 to 8% and from 2 to 10%, respectively, and carboxymethylating the reduced cytolysin preparation with iodoacetamide before electrophoresis did not cause a detectable increase in the amounts of the 48,000-and 16,500-molecularweight bands (data not shown). Therefore, it is unlikely (i) that only a small percentage of the cytolysin molecules were converted to the 48,000-and 16,500-molecular-weight fragments because of incomplete denaturation and reduction or (ii) that all of the cytolysin molecules were converted under reducing conditions to the two fragments, but most of the fragments were reoxidized to the native 56,000-molecularweight form because of the absence of reducing agent in the polyacrylamide gel.
At the present time, the idea we favor to explain the observation of the 48,000-and 16,500-molecular-weight com- ponents during SDS-PAGE is that a small percentage of the native, 56,000-molecular-weight cytolysin molecules exist in a proteolytically nicked form held together by intrachain disulfide bonds. The nicked molecules are indistinguishable from the intact cytolysin molecules during purification and comigrate with the intact molecules in the absence of reducing agents during SDS-PAGE; however, the nicked molecules separate into 48,000-and 16,500-molecular-weight frag- (41) , of the bands obtained by analytical thin-layer isoelectric focusing of partially purified (stage 2) and highly purified (stage 5) cytolysin preparations indicated that the cytolysin has an isoelectric point (pI) of ca. 7.1 (Fig. 5B ).
This value is similar to the pl obtained during preparative isoelectric focusing of the stage 4 cytolysin preparation (Fig.  3A) . However, the pI is substantially higher than the pI of 3.8 previously estimated (37) by preparative isoelectric focusing of crude cytolysin preparations. This difference suggests that the value obtained by preparative isoelectric focusing of the crude cytolysin may have been artificially low because of cytolysin interaction or complex formation with acidic contaminants in the preparation.
Amino acid analyses. The amino acid composition of the purified cytolysin is shown in Table 2 . The minimal molecular weight calculated from the total 480 residues was 55,700. The similarity of the molecular weights estimated by amino acid analysis and SDS-PAGE indicates that the cytolysin does not contain appreciable amounts of non-amino acid material. Basic, acidic, and nonpolar hydrophobic amino acid residues accounted for ca. 13, 22 , and 36% of the total residues, respectively. However, many of the aspartic acid and glutamic acid residues must occur as asparagine and glutamine because the pl of the cytolysin is ca. 7.1. The presence of eight half-cystine residues suggests that the cytolysin could have four intra-or interchain disulfide bonds. The first 10 amino-terminal amino acid residues of the purified cytolysin preparation were Gln-Glu-Tyr-Val-Pro-IleVal-Glu-Lys-Pro, and only a single amino acid sequence was detected in the preparation.
Inactivation studies. The ability of the purified cytolysin to lyse erythrocytes was not affected by phospholipids (cardiolipin, sphingomyelin, phosphatidylserine, phosphatidylcholine, phosphatidylinositol, and phosphatidylethanolamine; 100 ,ug), mixed gangliosides (100 ,ug), glycophorin (100 ,ug), dithiothreitol (5 x 10-3 M), chelating agents (EDTA and EGTA, 1 x 10-3 M), and divalent cations (Ca2+, Mg2+, and Zn2+; 1 x 10-3 M) (data not shown). However, the cytolysin was heat labile (56°C, 30 min), was partially inactivated by proteases and trypan blue, and was almost totally inactivated by an amount of cholesterol that is ca. 100-fold more than the dose commonly used to inactivate thiol-activated (oxygen-labile) cytolysins (Table 3 ). In addition, the cytolysin was unstable at pH 4, 6, 7, 8, and 10 (4°C for 24 h) unless crystalline BA was added (1 mg/ml) to the buffers (data not shown). The amino acid composition data does not support the idea that the cytolysin contains nonprotein structures; therefore, the only partial sensitivity of the cytolysin to various proteases suggests that the cytolysin has a tertiary structure in which the active site(s) is only partially exposed. 
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Cytolytic activity and variables influencing erythrocyte lysis. The cytolysin was active against erythrocytes from 17 animal species, but it was most active against pig, monkey, burro, cat, sheep, pigeon, and mouse erythrocytes ( Table 4) . The purified cytolysin preparation also was cytolytic for Chinese hamster ovary cells in tissue culture (data not shown). The minimal cytotoxic dose of purified cytolysin for the tissue culture cells was similar to the previously reported (22) minimal cytotoxic dose of crude cytolysin preparations and was ca. 0.1 HU (ca. 1 ng).
Variables affecting the hemolytic process were studied by using washed mouse erythrocytes as target cells. A decrease in percent hemolysis was observed when the target cell/cytolysin ratio was increased (Fig. 7) . In addition, the absolute amount of hemolysis (measured by absorbance at 545 nm) increased to a peak and then decreased. These observations suggest that more than one molecule of the cytolysin (a multi-hit process) is required to lyse a single erythrocyte (18-20, 27, 29) . When the dose-response data in Fig. 8 were used to construct a multi-hit survival curve as described by Inoue et al. (18) (the logarithm of the fraction of unlysed erythrocytes was plotted versus the cytolysin concentration), the ordinate intercept of the linear part of the curve indicated that hemolysis by the V. vulnificus cytolysin requires two or three hits (data not shown).
The manner in which rate of lysis depends upon concentration of cytolysin also was revealed by analysis of the curves shown in Fig. 8 . The result of plotting the slope of the linear part of each curve as a function of cytolysin concentration indicated that the rate of erythrocyte lysis is directly proportional to cytolysin concentration (data not shown).
The rate of erythrocyte lysis by the cytolysin was temperature-dependent and was optimal between 30 to 37°C ( the supernatant fluids with fresh erythrocytes at 37°C for 30 min. The cytolytic activity in the supernatant fluids progressively decreased with increased incubation time. Our results indicate that hemolysis by the V. vulnificus cytolysin is at least a two-step process, consisting of a temperature-independent, cytolysin-binding step, followed by a temperaturedependent, membrane-perturbation step(s) that leads to cell lysis.
Lethal and vascular permeability factor activities. The 50% lethal dose of the purified cytolysin preparation by the intravenous route (ca. 6 HU or 0.08 p,g per mouse [ca. 3 ,ug/kg]) was similar to the value previously estimated (22) for a crude cytolysin preparation administered by the intravenous route (5.2 HU). However, the 50% lethal dose of the purified cytolysin preparation by the intraperitoneal route (ca. 5,000 HU or 62.5 p,g per mouse [2.2 mg/kg]) was substantially greater than the value previously reported (22) for the crude cytolysin preparation injected by the intraperitoneal route (857 HU). Thus, although both cytolysin preparations were much more lethal for mice by intravenous injection than by intraperitoneal injection, the difference for the 50% lethal doses estimated by the two routes was ca. 830-fold for the purified cytolysin preparation but only 160-fold for the crude cytolysin preparation. One possible explanation for this fivefold difference is that the contaminants in the crude preparation enhance absorption of the cytolysin from the peritoneal cavity and, thus, indirectly increase the apparent toxicity of the preparation. For example, if the contaminants compete with the cytolysin for binding sites in the peritoneal cavity, the cytolysin would reach the bloodstream faster and in larger amounts after intraperitoneal injection of the crude preparation than after injection of the purified preparation.
The purified cytolysin preparation also had vascular permeability factor activity in guinea pig skin, and the activity was similar to that previously described (22) for the crude cytolysin preparation. One blueing dose was equivalent to 25 to 50 HU (0.3 to 0.6 ,ug) (data not shown).
In conclusion, the pharmacological activities of the purified V. vulnificus toxin described in this paper (cytolytic, vascular permeability factor, and lethal activities) are consistent with the pathological features of naturally occurring and experimentally induced disease caused by the bacterium (local edema and tissue necrosis, necrotizing vasculitis, hemolytic anemia, and death). We have, therefore, begun studies with the purified toxin to examine the possible importance of the toxin in the pathogenesis of disease caused by V. vulnificus.
